NCT06632340Completed
Effect of Tumor Base Size in Bladder Cancer
Effect of Tumor Base Size on Recurrence and Progression in Non-muscle Invasise Bladder Cancer
Source: ClinicalTrials.gov · Last updated 16 Oct 2024
Brief summary (registry, in English)
Investigators aim to investigate the effect of the size of the base of the tumor in contact with the bladder mucosa on recurrence and progression in non-muscle invasive bladder tumors.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 130 (actual)
- First submitted
- 7 Oct 2024
- Start date
- 1 Mar 2021
- Primary completion date
- 30 Sept 2023
- Lead sponsor
- Ankara Training and Research Hospital
- Diseases
- Bladder cancer
- NCT number
- NCT06632340
What you commit to
- Study type: Interventional
- Participants enrolled: 130
- From 1 Mar 2021 to the primary completion date, 30 Sept 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Invasive Bladder Tumor
Who the study is looking for
- Bladder Tumor
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ankara Training and Research Hospital Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.